Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Breast Neoplasms 52Ovarian Neoplasms 40Multiple Myeloma 20Fallopian Tube Neoplasms 13Lymphoma 12Sarcoma 11Carcinoma, Ovarian Epithelial 11Triple Negative Breast Neoplasms 8Recurrence 8Lymphoma, Large B-Cell, Diffuse 8Neoplasms 7Lymphoma, Non-Hodgkin 7Hodgkin Disease 6Neoplasms, Plasma Cell 5Sarcoma, Ewing 4Prostatic Neoplasms 4Neoplasm Metastasis 4Lymphoma, Mantle-Cell 4Burkitt Lymphoma 4Rhabdomyosarcoma 3Osteosarcoma 3Lymphoma, T-Cell, Peripheral 3Leiomyosarcoma 3Breast Neoplasms, Male 3Uterine Cervical Neoplasms 2Solid Tumors 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2

Interventions

Cyclophosphamide 30N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 21Prednisone 20Etoposide 20Vincristine 16Whole-Body Irradiation 15Doxorubicin 15fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 14romidepsin 13Mycophenolic Acid 12Lenalidomide 12Gemcitabine 12Cyclosporine 10Azacitidine 10Brentuximab Vedotin 9Bortezomib 9Alemtuzumab 8Dexamethasone 7Methotrexate 6Cytarabine 6Busulfan 6Carmustine 5pembrolizumab 4fludarabine 4Vorinostat 4Tacrolimus 4Rituximab 4Melphalan 4Ifosfamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Lymphoma, T-Cell, Peripheral × liposomal doxorubicin × Clear all
NCT00632827 2020-04-27

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

University of California, San Francisco

Phase 2 Terminated
21 enrolled 13 charts
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03952572 2019-05-16

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Peking University

Phase 3 Unknown
244 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03023358 2017-01-18

Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
174 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡